Astera Labs, Inc. Accrued Liabilities, Current decreased by 23.7% to $69.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.9%, from $47.77M to $69.23M. Over 2 years (FY 2023 to FY 2025), Accrued Liabilities, Current shows an upward trend with a 77.6% CAGR.
A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.
These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...
Standard across all industries for tracking short-term operational obligations.
current_liabilities_accrued_liabilities_current| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.74M | $34.12M | $49.48M | $69.49M | $59.62M | $47.77M | $74.81M | $75.15M | $90.68M | $69.23M |
| QoQ Change | — | +18.7% | +45.0% | +40.4% | -14.2% | -19.9% | +56.6% | +0.5% | +20.7% | -23.7% |
| YoY Change | — | — | — | — | +107.4% | +40.0% | +51.2% | +8.1% | +52.1% | +44.9% |